# Study in Locally Advanced Squamous Cell Carcinoma of Head and Neck

> **NCT01133678** · PHASE2 · TERMINATED · sponsor: **University of Chicago** · enrollment: 50 (actual)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **DRUG:** Everolimus
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01133678
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-05-04
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 50 (ACTUAL)
- **Why stopped:** Primary endpoint reached futility boundary
- **Last updated:** 2020-05-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01133678

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01133678, "Study in Locally Advanced Squamous Cell Carcinoma of Head and Neck". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01133678. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*